MSB 3.21% $1.13 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-568

  1. 6,921 Posts.
    lightbulb Created with Sketch. 1521
    personally, I give it a 99% chance of approval. I’d give it 100% but I like a bit of wriggle room!

    https://hotcopper.com.au/data/attachments/5123/5123890-1520d2a75a48ab3d6ff6c3f1ee4f43a4.jpg

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.